Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Number 4—April 2025
Synopsis

Alistipes Bacteremia in Older Patients with Digestive and Cancer Comorbidities, Japan, 2016–2023

Naoki WatanabeComments to Author , Tomohisa Watari, Naoto Hosokawa, and Yoshihito Otsuka
Author affiliation: Kameda Medical Center, Chiba, Japan

Main Article

Table 2

Patient characteristics and clinical course of Alistipes bacteremia in a tertiary care center, Japan, 2016–2023*

Case ID Age, y/sex Comorbid conditions Clinical symptoms Clinical diagnosis Therapy† Outcome (time)
1
80s/F
Hypertension, diabetes mellitus, lipid disorder, cerebral infarction history, rectal cancer
Abdominal pain, septic shock
Colon perforation, colonic obstruction
TZP and vancomycin (1 d)
Death
(1 d)
2
50s/M
None
Abdominal pain
Acute appendicitis
SAM (3 d), AMC (11 d), appendectomy
Alive, discharged
(6 d)
3
50s/F
Ovarian cancer, febrile neutropenia
Abdominal pain, fever
Perforated colon
SAM (24 d), TZP (12 d)
Alive, discharged
(50 d)
4
90s/F
Alzheimer’s-type dementia, Hypertension, epilepsy, chronic constipation
Abdominal pain, vomiting, diarrhea, fever
Acute appendicitis, secondary peritonitis, paralytic ileus, aspiration pneumonia
SAM (23 d), AMC (5 d)
Alive, discharged
(22 d)
5
60s/F
Diabetes mellitus, colon cancer
Abdominal pain, septic shock
Generalized peritonitis, intestinal perforation, Nonocclusive mesenteric ischemia, ovarian necrosis
TZP (2 d), cefmetazole (17 d), colectomy, small bowel resection, bilateral salpingo-oophorectomy
Alive, transferred
(114 d)
6
70s/M
Febrile neutropenia, previous hepatitis B virus infection, hypertension, diabetes mellitus, benign prostatic hyperplasia, acute myeloid leukemia
Fever, abdominal pain
Colonic diverticulitis
Cefepime and MTZ (10 d), SAM and MTZ (3 d)
Alive, discharged
(228 d)
7
30s/M
Epilepsy, under treatment for CRBSI with Staphylococcus aureus
Fever
Bacteremia of unknown origin
Cefazolin (5 d), SAM (12 d)
Alive, transferred
(41 d)
8
70s/M
Oral candida, adenocarcinoma (primary site unknown)
Septic shock, ascites, abdominal distension‡
Bowel obstruction
TZP (1 d), TZP and fluconazole (1 d)
Death
(1 d)
9
60s/F
Rectal cancer
Abdominal pain, vomiting
Colon perforation, peritonitis
TZP (1 d), SAM (14 d), Hartmann’s procedure
Alive, discharged
(28 d)
10
90s/F
Hypertension, dyslipidemia, osteoporosis, postoperative Mallory–Weiss syndrome, suspected aspiration pneumonia
Fever, tachycardia
Bowel obstruction
Cefotiam (4 d), SAM (15 d), intestinal resection
Alive, discharged
(44 d)
11
80s/F
Osteoporosis, dyslipidemia
Abdominal pain
Perforated appendicitis, peritonitis, intra-abdominal abscess
SAM (11 d), SAM and MTZ (8 d), appendectomy
Alive, discharged
(19 d)
12
70s/M
Cerebral infarction history, cholecystectomy history
Chills, fever, vomiting
Bacteremia of unknown origin
Ciprofloxacin and MTZ (3 d), ceftriaxone and MTZ (10 d)
Alive (outpatient)
13 80s/M Hypertension, cholecystectomy history, rectal cancer Abdominal pain Colorectal perforation SAM (10 d), TZP (12 d), Hartmann procedure Alive, discharged
(53 d)

*Bold text indicates cases in which multiple pathogens were detected as follows: 2, Alistipes onderdonkii, Bacteroides uniformis, Escherichia coli, and Pseudomonas nitroreducens; 5, A. putredinis and E. coli; 9, A. putredinis and Flavonifractor plautii; 10, A. indistinctus and Klebsiella pneumoniae; 11, 
A. onderdonkii and B. salyersiae; 13, A. finegoldii and A. ihumii. AMC, amoxicillin/clavulanic acid; CRBSI, catheter-related bloodstream infection; ID, identification; MTZ, metronidazole; SAM, ampicillin/sulbactam; transferred, transferred to another hospital; TZP, piperacillin/tazobactam. †Numbers in parentheses indicate duration of drug treatment. Most patients received multiple antimicrobial drugs; shown are the 2 used for the 
longest duration. ‡Patient had been experiencing abdominal distention caused by accumulation of ascites even before the onset of bacteremia.

Main Article

Page created: February 18, 2025
Page updated: March 24, 2025
Page reviewed: March 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external